Official AMFI data
Arthkar — Understand Money, Invest Smartly
Edelweiss

Edelweiss Small Cap Fund

Small CapEquityVery High risk Rank 13 of 27

NAV · Direct-Growth

₹54.74-0.23-0.43%

As of 1 Sept 2026 · AMFI

NAV growth+13.8%
Sep ’25Sep ’26
Arthkar verdictStrong on the numbers

Returns

Mixed vs category

1 of 3 periods ahead

Cost

Low

0.52% vs 0.68% peers

Volatility

Below average

18.1% vs 19.8% cat (3Y)

Consistency

Strong

positive in 6 of 7 years

Beats its Small Cap category on 5Y but trails on 1Y & 3Y — and has been steadier than peers.

1Y return

+13.8%

-2.7 vs cat

3Y CAGR

+16.8%

-0.4 vs cat

5Y CAGR

+18.7%

+0.8 vs cat

AUM

₹6.2K Cr

fund size

Expense

0.52%

direct plan

Volatility 3Y

18.1%

▼ vs 19.8%

Go deeper on Edelweiss Small Cap Fund

Two data-only views, computed from this fund's real NAV history — no projections.

In plain English

Edelweiss Small Cap Fund is a Small Cap scheme from Edelweiss. The portfolio is ~97% in equities. Long-run track record: about 18.7% CAGR over 5 years. Volatility is high — expect 30 %+ paper losses during major corrections. Worst historical drawdown: -37% in Mar 2020, recovered in 5 months. Wrong fit if you need this money in less than 7 years.

Auto-generated from holdings, returns and risk data. No paid placement, no copy-pasted boilerplate.

NAV history

Showing Direct · Growth · INF754K01JN6

NAV (Direct-Growth)

₹54.7430

Last 1Y

+13.78%

Sept 25Min ₹42.45 · Max ₹54.98 · 248 ptsSept 26

Drawdown stories

The crashes you should know about — and how long the fund took to recover.

Mar 2020

-37.1%

Peak ₹12.57 on 20 Feb 2020 → trough ₹7.91 on 23 Mar 2020 (1 months down).

Recovered in 5 months· 24 Aug 2020

Mar 2025

-22.9%

Peak ₹51.48 on 11 Dec 2024 → trough ₹39.71 on 3 Mar 2025 (3 months down).

Recovered in 16 months· 19 Jun 2026

Jun 2022

-19.1%

Peak ₹27.05 on 17 Jan 2022 → trough ₹21.87 on 20 Jun 2022 (5 months down).

Recovered in 3 months· 5 Sept 2022

Aug 2019

-14.9%

Peak ₹11.57 on 28 May 2019 → trough ₹9.85 on 5 Aug 2019 (2 months down).

Recovered in 5 months· 13 Jan 2020

Computed from the full NAV history. We show drawdowns deeper than 10%, sorted by depth.

Honesty score

A 1–5 grade on the dimensions other sites won't surface — expense bloat, AUM bloat, concentration, mandate compliance.

5

Honesty score

5 / 5

Solid scheme on the dimensions we check. No red flags.

  • Expense ratio

    0.52% — well below typical 1% for equity.

  • AUM size

    ₹6.2K Cr — manageable for a small-cap mandate.

  • Sector concentration

    Top 3 sectors = 57.4% — diversified across sectors.

  • Style drift

    Allocation matches the declared category mandate.

Computed from expense ratio, AUM, sector concentration and SEBI mandate compliance. No paid review.

Performance

Returns for various periods, with category average and peer rank.

PeriodReturnsCategory avgRank
1W+0.60%+0.34%12/ 40
1M+3.90%+4.13%21/ 40
3M+11.98%+11.97%22/ 40
6M+15.40%+20.00%27/ 38
YTD+11.94%+16.24%26/ 37
1Y+13.78%+16.43%22/ 35
2Y+5.36%+5.13%17/ 32
3Y+16.75%+17.13%13/ 27
5Y+18.69%+17.87%12/ 26
7Y+26.99%+25.64%6/ 22

Portfolio composition

Asset allocation

  • Equity97.38%
  • Cash2.62%

By market cap

  • Mid cap29.32%
  • Small cap67.95%
  • Others2.73%

Concentration

Holdings

92

Avg market cap

₹23.5K Cr

Top 10 stocks

24.25%

Top 5 stocks

14.03%

Top 3 sectors

57.41%

Top holdings

Top 15 positions by weight, latest disclosure.

#InstrumentSectorWeight
  • 2

    Multi Commodity Exchange of India Ltd

    3.50%
  • 3

    City Union Bank Ltd

    3.41%
  • 1

    Multi Commodity Exchange of India Ltd

    3.28%
  • 2

    City Union Bank Ltd

    3.26%
  • 4

    Karur Vysya Bank Ltd

    3.12%
  • 4

    Karur Vysya Bank Ltd

    2.72%
  • 5

    Ajanta Pharma Ltd

    2.47%
  • 6

    Indian Bank

    2.41%
  • 5

    KEI Industries Ltd

    2.27%
  • 7

    KEI Industries Ltd

    2.20%
  • 8

    UNO Minda Ltd

    2.16%
  • 6

    Ajanta Pharma Ltd

    2.13%
  • 9

    Krishna Institute of Medical Sciences Ltd

    2.13%
  • 7

    Radico Khaitan Ltd

    2.12%
  • 10

    APL Apollo Tubes Ltd

    2.10%

Fundamentals (vs category)

Portfolio-weighted ratios, compared with the category average.

MetricFundCategory avgDiff
  • P/E ratio31.7029.18+2.52
  • P/B ratio4.393.81+0.58
  • Price / Sales3.623.01+0.61
  • Price / Cash Flow27.6922.53+5.16
  • Dividend yield0.62%0.79%-0.17
  • Return on equity (ROE)16.53%15.59%+0.94

Risk metrics

Standard deviation, Sharpe, Sortino, Beta — all vs category average.

Metric1Y3Y5YCat 1YCat 3YCat 5Y
  • Standard deviation

    Volatility — lower means steadier returns.

    20.0018.2916.7321.6519.7917.83
  • Sharpe ratio

    Risk-adjusted return — higher is better.

    0.050.710.790.090.610.68
  • Sortino ratio

    Like Sharpe but only counts downside volatility.

    0.081.131.310.201.001.11
  • Beta

    1 = moves with the market. <1 = less volatile.

    0.810.800.790.910.860.82

Peers in Small Cap

Other schemes in the same SEBI category, ranked by AUM.

Available plans & options

PlanOptionFull nameISIN

Click a plan to see its NAV and chart above. Direct plans have lower expense ratios than Regular — same portfolio, more of the return stays with you.